Cereno Scientific announced that the agreement with Mangold Fondkommission to act as liquidity provider for the company's share has been terminated. The share has a good spread and a liquidity provider is therefore no longer needed. The assignment will end on December 29, 2020, without a new liquidity provider agreement replacing the previous commitment.